-
1
-
-
57349116772
-
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon
-
Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, Wright EC, et al. Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. N Engl J Med 2008;/359:/2429-41.
-
(2008)
N Engl J Med
, vol.359
, pp. 2429-2441
-
-
Di Bisceglie, A.M.1
Shiffman, M.L.2
Everson, G.T.3
Lindsay, K.L.4
Everhart, J.E.5
Wright, E.C.6
-
2
-
-
70350638674
-
Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients
-
Epub ahead of print
-
George SL, Bacon BR, Brunt EM, Mihindukulasuriya KL, Hoffmann J, Di Bisceglie AM. Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients. Hepatology 2008; Epub ahead of print.
-
(2008)
Hepatology
-
-
George, S.L.1
Bacon, B.R.2
Brunt, E.M.3
Mihindukulasuriya, K.L.4
Hoffmann, J.5
Di Bisceglie, A.M.6
-
3
-
-
0035975595
-
Hepatitis C virus core protein modulates the interferon-induced transacting factors of Jak/Stat signaling pathway but does not affect the activation of downstream IRF-1 or 561 gene
-
Basu A, Meyer K, Ray RB, Ray R. Hepatitis C virus core protein modulates the interferon-induced transacting factors of Jak/Stat signaling pathway but does not affect the activation of downstream IRF-1 or 561 gene. Virology 2001;/288:/379-90.
-
(2001)
Virology
, vol.288
, pp. 379-390
-
-
Basu, A.1
Meyer, K.2
Ray, R.B.3
Ray, R.4
-
4
-
-
0032731641
-
Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation
-
Shimoike T, Mimori S, Tani H, Matsuura Y, Miyamura T. Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation. J Virol 1999;/73:/ 9718-25.
-
(1999)
J Virol
, vol.73
, pp. 9718-9725
-
-
Shimoike, T.1
Mimori, S.2
Tani, H.3
Matsuura, Y.4
Miyamura, T.5
-
5
-
-
0034602420
-
Hepatitis C core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability
-
Otsuka M, Kato N, Lan K-H, Yoshida H, Kato J, Goto T, et al. Hepatitis C core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J Biol Chem 2000;/275:/34122-30.
-
(2000)
J Biol Chem
, vol.275
, pp. 34122-34130
-
-
Otsuka, M.1
Kato, N.2
Lan, K.-H.3
Yoshida, H.4
Kato, J.5
Goto, T.6
-
6
-
-
55549090712
-
Hepatitis C virus core protein augments androgen receptor-mediated signaling
-
Kanda T, Steele R, Ray R, Ray RB. Hepatitis C virus core protein augments androgen receptor-mediated signaling. J Virol 2008;/82:/11066-72.
-
(2008)
J Virol
, vol.82
, pp. 11066-11072
-
-
Kanda, T.1
Steele, R.2
Ray, R.3
Ray, R.B.4
-
7
-
-
26944444737
-
Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-beta pathway
-
Pavio N, Battaglia S, Boucreux D, Arnulf B, Sobesky R, Hermine O, et al. Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-beta pathway. Oncogene 2005;/24:/6119-32.
-
(2005)
Oncogene
, vol.24
, pp. 6119-6132
-
-
Pavio, N.1
Battaglia, S.2
Boucreux, D.3
Arnulf, B.4
Sobesky, R.5
Hermine, O.6
-
8
-
-
3242891546
-
Effects of the hepatitis C virus core protein on innate cellular defense pathways
-
Miller K, McArdle S, Gale M Jr, Geller DA, Tenoever B, Hiscott J, et al. Effects of the hepatitis C virus core protein on innate cellular defense pathways. J Interferon Cytokine Res 2004;/24:/391-402.
-
(2004)
J Interferon Cytokine Res
, vol.24
, pp. 391-402
-
-
Miller, K.1
McArdle, S.2
Gale Jr., M.3
Geller, D.A.4
Tenoever, B.5
Hiscott, J.6
-
9
-
-
9144257569
-
Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection
-
DOI 10.1056/NEJM199601113340203
-
Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996;/ 334:/77-81. (Pubitemid 26017933)
-
(1996)
New England Journal of Medicine
, vol.334
, Issue.2
, pp. 77-81
-
-
Enomoto, N.1
Sakuma, I.2
Asahina, Y.3
Kurosaki, M.4
Murakami, T.5
Yamamoto, C.6
Ogura, Y.7
Izumi, N.8
Marumo, F.9
Sato, C.10
-
10
-
-
8444233615
-
Inhibition of subgenomic hepatitis C virus RNA in Huh-7 cells: Ribavirin induces mutagenesis in HCV RNA
-
Kanda T, Yokosuka O, Imazeki F, Tanaka M, Shino Y, Shimada H, et al. Inhibition of subgenomic hepatitis C virus RNA in Huh-7 cells: ribavirin induces mutagenesis in HCV RNA. J Viral Hepat 2004;/11:/479-87.
-
(2004)
J Viral Hepat
, vol.11
, pp. 479-487
-
-
Kanda, T.1
Yokosuka, O.2
Imazeki, F.3
Tanaka, M.4
Shino, Y.5
Shimada, H.6
-
11
-
-
22344457187
-
Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy
-
Akuta N, Suzuki F, Sezaki H, Suzuki Y, Hosaka T, Someya T, et al. Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy. Intervirology 2005;/48:/372-80.
-
(2005)
Intervirology
, vol.48
, pp. 372-380
-
-
Akuta, N.1
Suzuki, F.2
Sezaki, H.3
Suzuki, Y.4
Hosaka, T.5
Someya, T.6
-
12
-
-
34547130793
-
Pretreatment sequence diversity differences in the fulllength hepatitis C virus open reading frame correlate with early response to therapy
-
Donlin MJ, Cannon NA, Yao E, Li J, Wahed A, Taylor MW, et al. Pretreatment sequence diversity differences in the fulllength hepatitis C virus open reading frame correlate with early response to therapy. J Virol 2007;/81:/8211-24.
-
(2007)
J Virol
, vol.81
, pp. 8211-8224
-
-
Donlin, M.J.1
Cannon, N.A.2
Yao, E.3
Li, J.4
Wahed, A.5
Taylor, M.W.6
-
13
-
-
33846593397
-
Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels
-
Akuta N, Suzuki F, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, et al. Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholesterol levels. J Hepatol 2007;/46:/ 403-10.
-
(2007)
J Hepatol
, vol.46
, pp. 403-410
-
-
Akuta, N.1
Suzuki, F.2
Kawamura, Y.3
Yatsuji, H.4
Sezaki, H.5
Suzuki, Y.6
-
14
-
-
0024605518
-
Analysis of any point mutation in DNA. the amplification refractory mutation system (ARMS)
-
Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989;/17:/2503-16.
-
(1989)
Nucleic Acids Res
, vol.17
, pp. 2503-2516
-
-
Newton, C.R.1
Graham, A.2
Heptinstall, L.E.3
Powell, S.J.4
Summers, C.5
Kalsheker, N.6
-
15
-
-
0027232296
-
Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma
-
Tada M, Omata M, Kawai S, Saisho H, Ohto M, Saiki R, et al. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 1993;/53:/2472-4.
-
(1993)
Cancer Res
, vol.53
, pp. 2472-2474
-
-
Tada, M.1
Omata, M.2
Kawai, S.3
Saisho, H.4
Ohto, M.5
Saiki, R.6
-
16
-
-
0032212690
-
Quantitative analysis of GBV-C RNA in liver and serum by strand-specific reverse transcription-polymerase chain reaction
-
Kanda T, Yokosuka O, Tagawa M, Kawai S, Imazeki F, Saisho H. Quantitative analysis of GBV-C RNA in liver and serum by strand-specific reverse transcription-polymerase chain reaction. J Hepatol 1998;/29:/707-14.
-
(1998)
J Hepatol
, vol.29
, pp. 707-714
-
-
Kanda, T.1
Yokosuka, O.2
Tagawa, M.3
Kawai, S.4
Imazeki, F.5
Saisho, H.6
-
17
-
-
33645011764
-
State of hepatitis C viral replication enhances activation of NF-kB- and AP- 1-signaling induced by hepatitis B virus X
-
Kanda T, Yokosuka O, Nagao K, Saisho H. State of hepatitis C viral replication enhances activation of NF-kB- and AP- 1-signaling induced by hepatitis B virus X. Cancer Lett 2006;/234:/143-8.
-
(2006)
Cancer Lett
, vol.234
, pp. 143-148
-
-
Kanda, T.1
Yokosuka, O.2
Nagao, K.3
Saisho, H.4
-
18
-
-
33847036713
-
A nucleotide sequence variation detection system for the core region of hepatitis C virus-1b
-
Okamoto K, Akuta N, Kumada H, Kobayashi M, Matsuo Y, Tazawa H. A nucleotide sequence variation detection system for the core region of hepatitis C virus-1b. J Virol Methods 2007;/141:/1-6.
-
(2007)
J Virol Methods
, vol.141
, pp. 1-6
-
-
Okamoto, K.1
Akuta, N.2
Kumada, H.3
Kobayashi, M.4
Matsuo, Y.5
Tazawa, H.6
-
19
-
-
50649112802
-
Treatment predictors of a sustained virologic response in hepatitis B and C
-
Kau A, Vermehren J, Sarrazin C. Treatment predictors of a sustained virologic response in hepatitis B and C. J Hepatol 2008;/49:/634-51.
-
(2008)
J Hepatol
, vol.49
, pp. 634-651
-
-
Kau, A.1
Vermehren, J.2
Sarrazin, C.3
-
20
-
-
47249110211
-
Ribavirin plus either peginterferon alpha-2a or peginterferon alpha-2b for patients with chronic HCV infection?
-
Herrmann E, Zeuzem S. Ribavirin plus either peginterferon alpha-2a or peginterferon alpha-2b for patients with chronic HCV infection? Nat Clin Pract Gastroenterol Hepat 2008;/5:/ 362-3.
-
(2008)
Nat Clin Pract Gastroenterol Hepat
, vol.5
, pp. 362-363
-
-
Herrmann, E.1
Zeuzem, S.2
-
21
-
-
34548660545
-
Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C
-
Di Bisceglie AM, Ghalib RH, Hamzeh FM, Rustgi VK. Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C. J Viral Hepat 2007;/14:/ 721-9.
-
(2007)
J Viral Hepat
, vol.14
, pp. 721-729
-
-
Di Bisceglie, A.M.1
Ghalib, R.H.2
Hamzeh, F.M.3
Rustgi, V.K.4
-
22
-
-
34748887873
-
Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis
-
Akuta N, Suzuki F, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, et al. Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis. Hepatology 2007;/46:/1357-64.
-
(2007)
Hepatology
, vol.46
, pp. 1357-1364
-
-
Akuta, N.1
Suzuki, F.2
Kawamura, Y.3
Yatsuji, H.4
Sezaki, H.5
Suzuki, Y.6
-
23
-
-
0032915574
-
Quantification of hepatitis C virus by TaqMan PCR: Comparison with HCVAmplicor Monitor assay
-
Kawai S, Yokosuka O, Kanda T, Imazeki F, Maru Y, Saisho H. Quantification of hepatitis C virus by TaqMan PCR: comparison with HCVAmplicor Monitor assay. J Med Virol 1999;/58:/121-6.
-
(1999)
J Med Virol
, vol.58
, pp. 121-126
-
-
Kawai, S.1
Yokosuka, O.2
Kanda, T.3
Imazeki, F.4
Maru, Y.5
Saisho, H.6
-
24
-
-
60049090076
-
A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: Amino acid substitutions in HCV core region as predictor of sustained virological response
-
Akuta N, Suzuki F, Hirakawa M, Kawamura Y, Yatsuji H, Sezaki H, et al. A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response. J Med Virol 2009;/81:/452-8.
-
(2009)
J Med Virol
, vol.81
, pp. 452-458
-
-
Akuta, N.1
Suzuki, F.2
Hirakawa, M.3
Kawamura, Y.4
Yatsuji, H.5
Sezaki, H.6
-
25
-
-
59849093175
-
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease
-
Lok AS, Seeff LB, Morgan TR, Di Bisceglie AM, Sterling RK, Curto TM, et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology 2009;/136:/138-48.
-
(2009)
Gastroenterology
, vol.136
, pp. 138-148
-
-
Lok, A.S.1
Seeff, L.B.2
Morgan, T.R.3
Di Bisceglie, A.M.4
Sterling, R.K.5
Curto, T.M.6
|